Prospective Study of White Blood Cells
The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies.
| Condition(s) | Autoimmune Diseases, Inflammation, Rejection; Transplant, Liver |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies. |
| Who can participate | No additional inclusion/ exclusion criteria will be applied by Quell other than those specified by the consenting institutions. |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Quell Therapeutics Limited |
| Locations | London, United Kingdom |
| Start date | 2021-03-24 |
| NCT ID | NCT04838171 |
| Official listing | https://clinicaltrials.gov/study/NCT04838171 |